Bioxodes Announces Positive Phase 2a Interim Data for BIOX-101
Bioxodes SA announced positive interim results from its Phase 2a BIRCH trial of BIOX-101 for intracerebral hemorrhagic stroke (ICH)....
Mineralys Therapeutics Publishes Pivotal Phase 2 ADVANCE-HTN Results in NEJM
Mineralys Therapeutics announced positive Phase 2 Advance-HTN trial results for lorundrostat, a novel treatment for uncontrolled or resistant hypertension...
Oncology Institute & Helios Partner to Expand Cancer Trials
The Oncology Institute (TOI) is expanding its partnership with Helios Clinical Research to bring clinical trials to more community...
Dexter Surgical Robot: Distalmotion Advances with Milestones
Distalmotion, a MedTech company specializing in robotic surgery, has completed clinical trials for cholecystectomy and benign hysterectomy in the...
AP Biosciences Doses First Patient in AP402 Phase 1/2 Trials
AP Biosciences has dosed the first patient in a Phase 1 trial of AP402, a novel T cell engager...
March Biosciences MB-105 Dosed in First T-Cell Lymphoma Patient
March Biosciences has dosed the first patient in a Phase 2 clinical trial for MB-105, a CD5-targeted CAR-T cell...
Kymera Doses First Patient in KT-621 Atopic Dermatitis Trial
Kymera Therapeutics has initiated its BroADen Phase 1b clinical trial for KT-621, an oral STAT6 degrader, in patients with...
Savolitinib Shows Promise in Gastric Cancer: Phase II Trial Completed
HUTCHMED has completed enrollment for the registration phase of its Phase II savolitinib trial in gastric cancer patients with...
GeneSight Test Reduces Psychiatric Hospitalizations in Depression Patients
A study published in the Journal of Clinical Psychopharmacology revealed that patients with major depressive disorder experienced fewer psychiatric...
Achieve Life Sciences Publishes Smoking Cessation Trial Results in JAMA
Achieve Life Sciences announced complete results from its ORCA-3 trial, published in JAMA Internal Medicine, demonstrating cytisinicline’s efficacy in...